MedPath

Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?

Completed
Conditions
Septic Shock
Registration Number
NCT02116413
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

The main objective of this study is to evaluate in a population of patients with septic shock receiving 500 ml crystalloid over 10 minutes, the proportion of patients classified as "responders" to the fluid challenge (increase of at least 15% of ITV in aortic) at the end of vascular filling (T10) and becoming "non-responders" 20 minutes after the end of the fluid challenge (T30) and whether this proportion is greater than 10 points.

Detailed Description

The secondary objectives of this study are :

A. To assess changes in different ultrasound parameters: E wave , E / A ratio , E / E ' in the event of vascular filling and construct a dose response curve for vascular filling.

B. To determing a threshold value for the mitral E wave velcoity that can predict a positive response to volume expansion at T10 defined by a 15% increase in the sub aortic velocity time integral (ITV) after 500 ml of crystalloids in 10 minutes.

C. To determine a threshold value for theITV at T0 that can predict a positive response to volume expansion at T10 defined by a 15% increase in the ITV after 500 ml of crystalloids in 10 minutes.

D. To evaluate the proportion of responders at T10 becoming non-responders at T20.

E. To evaluate the proportion of nonresponders at T10 and responders at T30 .

F. To estimate the proportion of patients changing status regardless of the direction of change between T10 and T30 .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
145
Inclusion Criteria
  • The patient has given his/hers consent or the patient is in an emergency situation (commitment to obtain the consent of the patient as soon as his/her condition permits)
  • Patient affiliated or beneficiary of a health insurance plan
  • Patient with septic shock: proven or suspected infection associated with hypotension or lactate> 4 mmol / l or organ dysfunction. Hypotension despite fluid resuscitation of 20 to -40 ml / kg.
  • Patient under controlled mechanical ventilation
  • Patient requiring vascular filling according to the following criteria:
  • oliguria <0.5 ml / kg / h for at least 2h
  • skin mottling
  • Arterial Lactate > 2 mmol / l
  • SvcO2 <70% or SvO2 <65%
  • Patient on noradrenaline.
Exclusion Criteria
  • The patient is has in another interventional study that might change the results of this study within the past 3 months
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient refuses to sign the consent
  • The patient is pregnant, parturient, or breastfeeding
  • Valvular pathology: grade III and IV aortic or mitral insufficiency
  • Non sinus electrocardiogram
  • Non-echogenic patient
  • Patient with any spontaneous breathing
  • Moribund patient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient status changes from "responder" at the end of the fluid challenge (T10) to "non-responder" 20 minutes after the end of the fluid challenge (T30).30 minutes
Secondary Outcome Measures
NameTimeMethod
Mitral E wave30 minutes
Mitral A wave30 minutes
E' Wave at the lateral mitral annulus30 minutes
ITV30 minutes
Patient status changes from "responder" at the end of the fluid challenge (T10) to "non-responder" 10 minutes after the end of the fluid challenge (T20).20 minutes
Patient status changes from "non-responder" at the end of the fluid challenge (T10) to "responder" 20 minutes after the end of the fluid challenge (T30).30 minutes

Trial Locations

Locations (9)

CHU d'Amiens - Hôpital Nord

🇫🇷

Amiens Cedex 1, France

CHU de Besançon - Hôpital Jean Minjoz

🇫🇷

Besançon, France

CHU de Caen - Hôpital Côte de Nacre

🇫🇷

Caen Cedex 9, France

CHU de Clermont Ferrand - Hôpital Estaing

🇫🇷

Clermont Ferrand, France

CHU de Clermont Ferrand - Hôpital Gabriel-Montpied

🇫🇷

Clermont Ferrand, France

APHM - Hôpital Nord

🇫🇷

Marseille Cedex 20, France

CHU de Nantes - Hôpital Guillaume et René Laennec

🇫🇷

Nantes, France

CHU de Nice - Hôpital St-Roch

🇫🇷

Nice Cedex 1, France

CHRU de Nîmes - Hôpital Universitaire Carémeau

🇫🇷

Nîmes Cedex 09, France

CHU d'Amiens - Hôpital Nord
🇫🇷Amiens Cedex 1, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.